Sample to Answer Clinical Series

Facebooktwitterredditpinterestlinkedinmail

BD, one of the largest global medical technology companies in the world, will launch the Sample to Answer Clinical Series, December 9, 2020. Opening at 10:30am EST, BD is excited to share how other clinical labs are improving the way they process clinical samples with automation. It is a series you will not want to miss.

The first session on December 9, 2020 will serve as an opportunity for you to learn more about ways to improve the efficiency of your clinical lab. By using the BD FACSDuet Sample Preparation System integrated with the BD FACSLyric Flow Cytometer, clinical labs can improve accuracy and standardization from instrument-to-instrument and operator-to-operator, enhancing throughput and providing consistent results that clinicians depend on to inform patient care.

Attending the Sample to Answer Clinical Series will give you the opportunity to:
• Meet BD’s clinical sales team
• Network with other event attendees
• Learn new ways to improve the efficiency of your clinical lab
• Hear from various speakers on standardization and efficiency within the clinical flow cytometry workflow

You will also be able to explore posters, countless resources, and on-demand videos. For more information regarding the series and the first session, click here.

About BD:
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Specifically, BD Life Sciences – Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.

About LabRoots:
LabRoots is the leading scientific social networking website, as well as a primary source for scientific trending news, premier educational virtual events/webinars and more. Contributing to the advancement of science through content-sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining Continuing Education Credits from a wide range of topics through their participation in the webinars and virtual events.

Avatar
admin@labroots.com
No Comments

Sorry, the comment form is closed at this time.